Biological Therapy Analysis & Statistics, July 2013 (p8)

Talk to Louis

+1 718 618 4302

All regions

You might be interested in: stem cell, tissue engineering, cell therapy, more »

211-240 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Genetrix SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genetrix SL - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Genetrix SL (Genetrix) is a biotechnology company. It manufactures and markets product offering biotechnological solutions. The company consists of technology development companies including Sygnis, ...

  • Industries : Biological Therapy
RNL BIO Co., Ltd. (CBTEQ.PK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

RNL BIO Co., Ltd. (CBTEQ.PK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary RNL BIO Co., Ltd. (RNL BIO) is a biotechnology company, based in Republic of Korea. The company develops, manufactures and markets stem cell therapy products. It offers products and services in ...

  • Industries : Biological Therapy
  • Countries : South Korea
Gamida Cell Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Gamida Cell Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Gamida Cell Ltd. (Gamida) is a health care company. The company is into development of therapeutic products. Its product StemEx is used for the treatment of leukemia, lymphoma, krabbe disease, ...

  • Industries : Biological Therapy
ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

ES Cell International Pte Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary ES Cell International Pte, Ltd. (ESI) is a regenerative medicine company, based in Singapore. The company develops human embryonic stem cell technologies for research and commercial applications. ...

  • Industries : Biological Therapy
  • Countries : Singapore
Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Verastem, Inc. (VSTM) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Verastem, Inc. (Verastem) is a clinical-stage biopharmaceutical company. It discovers and develops drugs for the treatment of cancer by the targeted killing of cancer stem cells. The company develops ...

  • Industries : Biological Therapy
  • Countries : United States
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Stem Cell Innovations, Inc. (SCLL)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: Stem Cell Innovations, Inc. (SCLL)

  • $ 250
  • Company report
  • July 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
Bionet Corp. (1784) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Bionet Corp. (1784) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary BIONET Corp. (BIONET) is a pharmaceutical service provider. The company provides cord blood private banking service in Taiwan. BIONET's products include cord blood, mesenchymal stem cells, dental ...

  • Industries : Biological Therapy
  • Countries : Taiwan
Pathfinder Cell Therapy, Inc. (PFND) - Medical Equipment - Deals and Alliances Profile

Pathfinder Cell Therapy, Inc. (PFND) - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • July 2013
  • by Global Data

Summary Pathfinder Cell Therapy, Inc. (Pathfinder Cell Therapy) is a regenerative medicine company. The company operates in segments such as adult and pediatric market. It is a development stage regenerative ...

  • Industries : Biological Therapy
  • Countries : United States
Biocompatibles International Ltd. - Strategic SWOT Analysis Review

Biocompatibles International Ltd. - Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • July 2013
  • by Global Data

Summary Biocompatibles International Ltd. (Biocompatibles) is a medical technology company, engaged in the development of products used for the treatment of cancer and benign tumors. The company is divided ...

  • Industries : Biological Therapy
  • Countries : United States, United Kingdom
Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

  • $ 4 595
  • Industry report
  • June 2013
  • by Transparency Market Research

Stem Cells Market (Adult, Human Embryonic , Induced Pluripotent, Rat-Neural, Umbilical Cord, Cell Production, Cell Acquisition, Expansion, Sub-Culture) - Global Industry Analysis, Size, Share, Growth, ...

  • Industries : Biological Therapy
  • Countries : World
International Brachytherapy s.a. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

International Brachytherapy s.a. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Stem Cell Sciences plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Stem Cell Sciences plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Cytokine PharmaSciences, Inc. (formerly Cytokine Networks, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Cytokine PharmaSciences, Inc. (formerly Cytokine Networks, Inc.) - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
Stem Cell Sciences plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

Stem Cell Sciences plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
California Stem Cell, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

California Stem Cell, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

  • $ 350
  • Company report
  • June 2013
  • by MarketLine

Project Synopsis: MarketLine's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken ...

  • Industries : Biological Therapy
  • Countries : United States
Mesenchymal Stem Cells, Advances & Applications

Mesenchymal Stem Cells, Advances & Applications

  • $ 3 495
  • Industry report
  • June 2013
  • by BioInformant Worldwide, L.L.C.

Mesenchymal stem cells (MSCs) are multipotent stem cells that can differentiate into a variety of cell types, including osteoblasts, chondrocytes, myocytes, adipocytes, beta-pancreatic islets cells, and ...

  • Industries : Biological Therapy
Complete 2012-13  Induced Pluripotent Stem Cell Industry Report

Complete 2012-13 Induced Pluripotent Stem Cell Industry Report

  • $ 3 450
  • Industry report
  • June 2013
  • by BioInformant Worldwide, L.L.C.

EXECUTIVE SUMMARY Stem cell research and experimentation has been in process for well over five decades, as stem cells have the unique ability to divide and replicate repeatedly. In addition, their ...

  • Industries : Biological Therapy
  • Countries : United States
Global Gene Therapy Market Analysis

Global Gene Therapy Market Analysis

  • $ 1 200
  • Industry report
  • June 2013
  • by RNCOS

Gene therapy is the treatment of a disease by replacing, altering, or supplementing a gene that is absent or abnormal and whose absence or abnormality is causing the disease. It has evolved as one of the ...

  • Industries : Biological Therapy
  • Countries : World
Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013

Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013

  • $ 1 500
  • Company report
  • May 2013
  • by Global Markets Direct

Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013 Summary Global Market Direct's pharmaceuticals report, ?Cytokine PharmaSciences, Inc. - Product Pipeline Review - 2013? provides data on ...

  • Industries : Biological Therapy
  • Countries : World
Cell Therapy in the US - Industry Market Research Report

Cell Therapy in the US - Industry Market Research Report

  • $ 1 020
  • Industry report
  • May 2013
  • by Ibisworld

Cell Therapy The Cell Therapy industry is a fast-growing industry. The demand for the industry's products and services depends primarily on the level of investment in medical technology. Strong growth ...

  • Industries : Biological Therapy
  • Countries : United States
Eckert & Ziegler BEBIG S.A. (EZBG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Eckert & Ziegler BEBIG S.A. (EZBG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2013
  • by Global Data

Summary Eckert & Ziegler BEBIG S.A. (Eckert & Ziegler) formerly International Brachytherapy S.A. is a Europe-based medical device company, it focuses on treatment of cancer using brachytherapy, a special ...

  • Industries : Biological Therapy
Merger & Acquisition in Pharmaceuticals & Healthcare Industry: NeoStem, Inc. (NBS)

Merger & Acquisition in Pharmaceuticals & Healthcare Industry: NeoStem, Inc. (NBS)

  • $ 250
  • Company report
  • May 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
TiGenix NV (TIG) - Product Pipeline Analysis, 2013 Update

TiGenix NV (TIG) - Product Pipeline Analysis, 2013 Update

  • $ 750
  • Company report
  • May 2013
  • by Global Data

Summary TiGenix NV (TiGenix) is a biomedical cell therapy company. The company specializes in the development of innovative local treatments for damaged and diseased tissues. It mainly focuses on the therapeutic ...

  • Industries : Biological Therapy
  • Countries : Spain
iPS cell Generation patent landscape - 2013/03

iPS cell Generation patent landscape - 2013/03

  • $ 6 860
  • Industry report
  • May 2013
  • by France Innovation Scientifique et Transfert

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, China
iPS cell Differentiation patent landscape - 2013/03

iPS cell Differentiation patent landscape - 2013/03

  • $ 4 060
  • Industry report
  • May 2013
  • by France Innovation Scientifique et Transfert

Many diseases such as cardiovascular disorders, diabetes or neurodegenerative diseases are the consequences of dysfunction of specific cells. Strategies were developed to repair or regenerate the damaged ...

  • Industries : Biological Therapy
  • Countries : United States, South Korea, China
Chip-Man Technologies Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Chip-Man Technologies Ltd. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • April 2013
  • by Global Data

Summary Chip-Man Technologies Ltd. (Chip-Man) is a healthcare technology company, based in Finland. The company conducts research, develops, manufactures and commercializes medical products. It offers ...

  • Industries : Biological Therapy
  • Countries : Finland
Maxygen, Inc. (Symbol:MAXY) SWOT Analysis, Strategy, Revenues and Profits

Maxygen, Inc. (Symbol:MAXY) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • April 2013
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
SkinEthic Laboratories - Strategic SWOT Analysis Review

SkinEthic Laboratories - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • April 2013
  • by Global Data

SkinEthic Laboratories - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed ...

  • Industries : Biological Therapy
Competitor Analysis: G-CSF and GM-CSF

Competitor Analysis: G-CSF and GM-CSF

  • $ 528
  • Industry report
  • April 2013
  • by La Merie Publishing

Product description The present Competitive Intelligence Report about G-CSF and GM-CSF product portfolios and R&D pipelines provides a competitor evaluation in the field of G-CSF & GM-CSF branded products ...

  • Industries : Biological Therapy
  • Countries : Taiwan, South Korea, India, China
B-Cell Leukemia - Pipeline Review, H1 2013

B-Cell Leukemia - Pipeline Review, H1 2013

  • $ 2 000
  • Industry report
  • February 2013
  • by Global Markets Direct

B-Cell Leukemia - Pipeline Review, H1 2013 Summary Global Markets Direct's, 'B-Cell Leukemia - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World

32 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

GlaxoSmithKline P.L.C.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.